Matches in Wikidata for { <http://www.wikidata.org/entity/Q90587201> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q90587201 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q90587201 description "scientific article published on 01 April 2020" @default.
- Q90587201 description "wetenschappelijk artikel" @default.
- Q90587201 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q90587201 name "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 name "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 type Item @default.
- Q90587201 label "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 label "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 prefLabel "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 prefLabel "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 P1433 Q90587201-40FE857E-FEF1-49F1-86BF-BC4293882FDD @default.
- Q90587201 P1476 Q90587201-77EB7403-C992-4EDC-9145-CD274A5D5BB7 @default.
- Q90587201 P2093 Q90587201-0705C7AB-446B-4402-9208-9218FF5C59BE @default.
- Q90587201 P2093 Q90587201-094CE207-40C9-4C6F-8603-FF0C4F490A1E @default.
- Q90587201 P2093 Q90587201-0EC6D4FD-50DB-4A52-8578-ED6E0EE09205 @default.
- Q90587201 P2093 Q90587201-106E20E8-CE9B-4909-9BA8-29E515F34EFF @default.
- Q90587201 P2093 Q90587201-3333AB97-AA0F-46E8-9922-8F10A2A1520A @default.
- Q90587201 P2093 Q90587201-635843AA-ECA3-4396-A6F4-DCD2B06FB476 @default.
- Q90587201 P2093 Q90587201-6A693E4C-6BDA-48E5-9E2E-B51E66C020F4 @default.
- Q90587201 P2093 Q90587201-6B488F42-65B2-46A5-8A1F-669D9E235A6D @default.
- Q90587201 P2093 Q90587201-72B00C40-B5E1-4AB0-966A-8F5A1D85D367 @default.
- Q90587201 P2093 Q90587201-7454D388-9E40-48D9-A06B-45BDA4754607 @default.
- Q90587201 P2093 Q90587201-7C5B8AF8-A576-40DB-A99A-92DE40507F48 @default.
- Q90587201 P2093 Q90587201-7CC5F3FF-6B31-4FFA-A605-04E7C1F6FA54 @default.
- Q90587201 P2093 Q90587201-8F62A262-7A23-40FF-AE5F-97A94C364B8D @default.
- Q90587201 P2093 Q90587201-97D5F9AC-4596-4C2F-BB01-450026F8E3AB @default.
- Q90587201 P2093 Q90587201-9D0EAF94-89E0-4EA1-B6E3-BEA4DBB92D45 @default.
- Q90587201 P2093 Q90587201-9D7BF342-F136-4960-80D9-0355394CAC0B @default.
- Q90587201 P2093 Q90587201-9E6ADF42-2ED3-4399-955A-CFA76C39133B @default.
- Q90587201 P2093 Q90587201-BBC44E12-7D71-4ECE-8C74-627EC13E3A9D @default.
- Q90587201 P2093 Q90587201-CBC0CC08-15F5-47BF-92ED-135959E21F60 @default.
- Q90587201 P2093 Q90587201-DAB3CEFE-5702-4A6C-8250-E33C04DF67E5 @default.
- Q90587201 P2093 Q90587201-DD767EFB-F41F-43F9-876C-1F8EF5666058 @default.
- Q90587201 P2093 Q90587201-FCAF4E56-2D85-451C-99A7-BD7F35DDFBF2 @default.
- Q90587201 P31 Q90587201-1B08C04E-0323-4B9D-B07D-B8F3C164EA50 @default.
- Q90587201 P356 Q90587201-4C10C683-3B44-4BF0-8175-F377CF9F2782 @default.
- Q90587201 P50 Q90587201-5437A1D8-B971-4C0D-9A42-4A00C3C1FC26 @default.
- Q90587201 P50 Q90587201-9D00A150-5533-4D96-98F6-1520ECD92C9D @default.
- Q90587201 P50 Q90587201-CA54AFED-10FC-44E1-9AAA-8088EA4ECBA5 @default.
- Q90587201 P50 Q90587201-E2C67E7A-463B-4D65-A3BB-C87E14E53AC3 @default.
- Q90587201 P50 Q90587201-EBD58BFE-92EC-4343-893B-AC3DD4D0B8D6 @default.
- Q90587201 P577 Q90587201-CC9BFF7E-1C8D-40E5-B713-9B1444AF3452 @default.
- Q90587201 P698 Q90587201-79C3DEAA-186A-47DB-84AB-FDB5AAF1D291 @default.
- Q90587201 P921 Q90587201-C66E0941-A1D0-43F4-98D5-962E344F8A34 @default.
- Q90587201 P356 ACS.JMEDCHEM.0C00045 @default.
- Q90587201 P698 32202790 @default.
- Q90587201 P1433 Q900316 @default.
- Q90587201 P1476 "Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer" @default.
- Q90587201 P2093 "Akiko Nagamori" @default.
- Q90587201 P2093 "Anna Mizutani" @default.
- Q90587201 P2093 "Eiki Shitara" @default.
- Q90587201 P2093 "Haruka Yoshida" @default.
- Q90587201 P2093 "Hiroo Koyama" @default.
- Q90587201 P2093 "Hiroyuki Seimiya" @default.
- Q90587201 P2093 "Kenichi Washizuka" @default.
- Q90587201 P2093 "Kouichi Kitamura" @default.
- Q90587201 P2093 "Masayuki Okue" @default.
- Q90587201 P2093 "Mikako Shirouzu" @default.
- Q90587201 P2093 "Minoru Yoshida" @default.
- Q90587201 P2093 "Myung-Kyu Jang" @default.
- Q90587201 P2093 "Shin Sato" @default.
- Q90587201 P2093 "Takashi Umehara" @default.
- Q90587201 P2093 "Takashi Watanabe" @default.
- Q90587201 P2093 "Takehiro Fukami" @default.
- Q90587201 P2093 "Takeshi Tsumura" @default.
- Q90587201 P2093 "Tsubasa Chikada" @default.
- Q90587201 P2093 "Yoko Yashiroda" @default.
- Q90587201 P2093 "Yui Mazaki" @default.
- Q90587201 P2093 "Yukiko Muramatsu" @default.
- Q90587201 P2093 "Yuko Kano" @default.
- Q90587201 P31 Q13442814 @default.
- Q90587201 P356 "10.1021/ACS.JMEDCHEM.0C00045" @default.
- Q90587201 P50 Q51923487 @default.
- Q90587201 P50 Q58324358 @default.
- Q90587201 P50 Q89445420 @default.
- Q90587201 P50 Q90587188 @default.
- Q90587201 P50 Q90587194 @default.
- Q90587201 P577 "2020-04-01T00:00:00Z" @default.
- Q90587201 P698 "32202790" @default.
- Q90587201 P921 Q18555025 @default.